Edition:
United Kingdom

Aerpio Pharmaceuticals Inc (ARPO.OQ)

ARPO.OQ on NASDAQ Stock Exchange Capital Market

2.99USD
3:41pm GMT
Change (% chg)

$-0.14 (-4.47%)
Prev Close
$3.13
Open
$3.10
Day's High
$3.10
Day's Low
$2.99
Volume
9,565
Avg. Vol
26,501
52-wk High
$4.35
52-wk Low
$1.58

Chart for

About

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing treatments for ocular disease. Its lead product candidate is AKB-9778. Its other two pipeline programs include AKB-4924 and ARP-1536. AKB-9778 is a small molecule activator of the Tie-2 pathway, which is being developed for the... (more)

Overall

No Ratios Available.

Financials

  ARPO.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -- -- --
ROI: -- 8.92 14.45
ROE: -- 10.08 15.96

Earnings vs. Estimates